Crescita Therapeutics Inc. announced that it has acquired INTEGA Skin Sciences Inc. Crescita announced that Gregory Orleski, the former Chief Executive Officer of INTEGA, has been appointed Chief Executive Officer of the company effective September 1, 2016 and will become a member of the board of directors. Mr. Orleski replaces Dan Chicoine as Chief Executive Officer. Mr. Chicoine will remain as the company's Executive Chairman and member of the company's board of directors.

Mario Laflamme has been appointed the company's new Chief Financial Officer effective September 6, 2016 replacing Stephen Lemieux who has resigned to pursue other opportunities. Mr. Laflamme is a seasoned CFO with experience in both public and private companies. In addition to Mr. Orleski, Mr. Thomas Schlader will also be joining the company board of directors.